Ignite Creation Date:
2024-05-06 @ 8:08 PM
Last Modification Date:
2024-10-26 @ 3:21 PM
Study NCT ID:
NCT06264544
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-02-20
First Post:
2024-02-09
Brief Title:
Trial to Evaluate the Efficacy of a Zinc Selenium and L-Tyrosine Supplement in the Prevention of Thyrotoxicosis in Subjects With r25191GA SEPP1 Polymorphism
Sponsor:
SLAB SOLOWAYS
Organization:
SLAB SOLOWAYS
Study Overview
Official Title:
A Randomized Double-Blind Placebo-Controlled Clinical Trial to Evaluate the Efficacy of a Zinc Selenium and L-Tyrosine Supplement in the Prevention of Thyrotoxicosis in Subjects With r25191GA SEPP1 Polymorphism
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ZEST-PREP
Brief Summary:
This randomized double-blind placebo-controlled trial evaluates the efficacy of a zinc selenium and L-tyrosine supplement in preventing thyrotoxicosis among adults aged 18-85 with elevated TPOAb levels and the r25191GA SEPP1 polymorphism The study excludes those with thyroid disease pregnantbreastfeeding women and individuals allergic to the supplement Key endpoints include changes in thyroid antibodies and hormones over a 6-month period With an estimated sample size of 150 participants per group accounting for a 20 dropout rate the trial seeks to demonstrate the supplements potential in reducing thyrotoxicosis risk through a genetically-informed approach
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None